PMID- 27931684 OWN - NLM STAT- MEDLINE DCOM- 20180116 LR - 20181113 IS - 2212-554X (Electronic) IS - 2212-5531 (Print) IS - 2212-5531 (Linking) VI - 5 IP - 4 DP - 2016 Dec TI - Inhibition of apoptosis by Rv2456c through Nuclear factor-kappaB extends the survival of Mycobacterium tuberculosis. PG - 426-436 LID - S2212-5531(16)30054-1 [pii] LID - 10.1016/j.ijmyco.2016.06.018 [doi] AB - Mycobacterium tuberculosis, the causative agent of tuberculosis, is an intracellular pathogen with several survival mechanisms aimed at subverting the host immune system. Apoptosis has been shown to be mycobactericidal, to activate CD8(+) T cells, and to be modulated by mycobacterial proteins. Since few mycobacterial proteins have so far been directly implicated in the interactions between M. tuberculosis and host cell apoptosis, we screened M. tuberculosis H37Rv transposon mutants to identify mutants that fail to inhibit cell death (FID). One of these FID mutants, FID19, had a transposon insertion in Rv2456c and is important for survival in host cells. The lack of the protein resulted in enhanced caspase-3 mediated apoptosis, which is probably due to an inability to activate nuclear factor-kappaB. Additionally, FID19 infection enhanced polyfunctional CD8(+) T cells and induced a higher frequency of interferon-gamma secreting immune cells in a murine model. Taken together, our data suggest that Rv2456c is important for the survival of H37Rv by subduing the innate and ultimately adaptive immune responses of its host by preventing apoptosis of the infected cell. Better understanding of the host-mycobacterial interactions may be beneficial to develop novel drug targets and engineer more efficacious vaccine strains against tuberculosis. CI - Copyright A(c) 2016 Asian-African Society for Mycobacteriology. Published by Elsevier Ltd. All rights reserved. FAU - Jurcic Smith, Kristen L AU - Jurcic Smith KL AD - Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC, USA. FAU - Lee, Sunhee AU - Lee S AD - Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC, USA; Department of Pathology, Duke University School of Medicine, Durham, NC, USA. Electronic address: Sunhee.lee@duke.edu. LA - eng GR - R21 AI090434/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20160721 PL - India TA - Int J Mycobacteriol JT - International journal of mycobacteriology JID - 101615660 RN - 0 (Apoptosis Regulatory Proteins) RN - 0 (Bacterial Proteins) RN - 0 (DNA Transposable Elements) SB - IM MH - Animals MH - *Apoptosis MH - Apoptosis Regulatory Proteins/*metabolism MH - Bacterial Proteins/*metabolism MH - Cell Line MH - DNA Transposable Elements MH - Disease Models, Animal MH - *Host-Pathogen Interactions MH - Humans MH - *Immunity, Innate MH - Mice, Inbred C57BL MH - *Microbial Viability MH - Mutagenesis, Insertional MH - Mycobacterium tuberculosis/immunology/*physiology MH - Tuberculosis/microbiology/pathology PMC - PMC5975360 MID - NIHMS966558 OTO - NOTNLM OT - Apoptosis OT - Mycobacterium tuberculosis OT - Tuberculosis OT - Vaccine COIS- Conflicts of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest. EDAT- 2016/12/10 06:00 MHDA- 2018/01/18 06:00 PMCR- 2018/05/30 CRDT- 2016/12/10 06:00 PHST- 2016/06/28 00:00 [received] PHST- 2016/06/30 00:00 [accepted] PHST- 2016/12/10 06:00 [entrez] PHST- 2016/12/10 06:00 [pubmed] PHST- 2018/01/18 06:00 [medline] PHST- 2018/05/30 00:00 [pmc-release] AID - S2212-5531(16)30054-1 [pii] AID - 10.1016/j.ijmyco.2016.06.018 [doi] PST - ppublish SO - Int J Mycobacteriol. 2016 Dec;5(4):426-436. doi: 10.1016/j.ijmyco.2016.06.018. Epub 2016 Jul 21.